Skip to main content
Daehan Nupharm Co.,Ltd. logo

Daehan Nupharm Co.,Ltd. — Investor Relations & Filings

Ticker · 054670 ISIN · KR7054670005 LEI · 988400PSHJB5UWD6MA19 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 184 across all filing types
Latest filing 2022-05-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 054670

About Daehan Nupharm Co.,Ltd.

https://www.dhnp.co.kr

Daehan Nupharm Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a wide range of health products. Its business is structured around four key segments: human pharmaceuticals, providing effective and safe therapeutics; animal health, offering products for both livestock and companion animals; biopharmaceuticals, focusing on the development of next-generation treatments such as cell therapy; and health functional foods. The company prioritizes innovation and quality through its dedicated research and development centers, aiming to advance health outcomes with scientifically-backed solutions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock pledge extensions) of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-05-03 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice regarding a change in the company's market classification (from 'Mid-sized Enterprise' to 'Blue-chip Enterprise') on the stock exchange. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general regulatory announcement regarding company status, it falls under the RNS (Regulatory Filings) category.
2022-04-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status, changes in ownership, and collateral agreements (pledges) of major shareholders. This falls under the category of Major Shareholding Notification.
2022-04-06 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from Daehan New Pharm regarding a 'Decision on Cash/In-kind Dividends'. It specifically details the dividend amount per share, the payment date, and the approval status. This falls directly under the category of dividend announcements.
2022-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of voting on agenda items such as financial statement approval, dividend declarations, and director/auditor compensation. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-21 Korean
소송등의판결ㆍ결정(일정금액이상의청구)(손해배상(기))
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding a court judgment on a lawsuit ('소송등의판결ㆍ결정'). It details the case name, parties involved, the court's decision (dismissal of appeal), and the impact on the company. Since this specifically concerns legal proceedings and litigation outcomes, it falls under the 'Legal Proceedings Report' category.
2022-03-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.